Loading clinical trials...
Loading clinical trials...
A Phase 1, First in Human, Dose-Escalation Study of TORL-2-307-MAB in Participants With Advanced Cancer
Conditions
Interventions
TORL-2-307-MAB
Locations
8
United States
Providence St. Jude Medical Center
Fullerton, California, United States
UCLA - JCCC Clinical Research Unit
Los Angeles, California, United States
Torrance Memorial Medical
Torrance, California, United States
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
Washington University School of Medicine-Siteman Cancer Center
St Louis, Missouri, United States
Seoul National University Hospital
Seoul, South Korea
Start Date
January 20, 2022
Primary Completion Date
December 15, 2024
Completion Date
December 15, 2025
Last Updated
October 22, 2024
NCT07177937
NCT06921928
NCT05919264
NCT07181681
NCT06257264
NCT07387068
Lead Sponsor
TORL Biotherapeutics, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions